Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-10,000
Closed -$4.52K 4304
2025
Q2
$4.52K Hold
10,000
﹤0.01% 3675
2025
Q1
$4.07K Hold
10,000
﹤0.01% 3714
2024
Q4
$6.62K Hold
10,000
﹤0.01% 3565
2024
Q3
$8.49K Hold
10,000
﹤0.01% 3417
2024
Q2
$6.67K Hold
10,000
﹤0.01% 3432
2024
Q1
$13K Hold
10,000
﹤0.01% 3242
2023
Q4
$5.73K Hold
10,000
﹤0.01% 3484
2023
Q3
$7.54K Hold
10,000
﹤0.01% 3282
2023
Q2
$7.3K Hold
10,000
﹤0.01% 3372
2023
Q1
$7.57K Hold
10,000
﹤0.01% 3384
2022
Q4
$9.61K Sell
10,000
-531
-5% -$750 ﹤0.01% 3309
2022
Q3
$23K Buy
10,531
+531
+5% +$1.83K ﹤0.01% 2968
2022
Q2
$35K Hold
10,000
﹤0.01% 2784
2022
Q1
$50K Sell
10,000
-548
-5% -$2.78K ﹤0.01% 2628
2021
Q4
$66K Buy
10,548
+306
+3% +$2.09K ﹤0.01% 2502
2021
Q3
$81K Buy
10,242
+242
+2% +$1.99K ﹤0.01% 2406
2021
Q2
$75K Buy
+10,000
New +$69.8K ﹤0.01% 2466

Other funds holding VXRT

US Bancorp's VXRT Position: Q3 2025 in Review

US Bancorp sold out of Vaxart (VXRT) in Q3 2025, closing a stake of 10,000 shares — an estimated $4.52K sold.

US Bancorp first reported a position in VXRT in Q2 2021 and held it in 17 quarters. The position peaked at $81K in Q3 2021. 17 funds tracked by Wall St. Rank hold VXRT as of Q3 2025.

  • US Bancorp reported no remaining Vaxart position as of Q3 2025 after selling out during the quarter.
  • US Bancorp sold 10,000 Vaxart shares in Q3 2025, an estimated $4.52K.
  • US Bancorp first reported a position in Vaxart in Q2 2021 and held it in 17 quarters.
  • US Bancorp's Vaxart position peaked at $81K in Q3 2021.
  • 17 funds tracked by Wall St. Rank held Vaxart as of Q3 2025.

Based on US Bancorp's 13F filing for Q3 2025, filed 12 Nov 2025.